Ascendis Pharma A/S (FRA:A71)
Germany · Delayed Price · Currency is EUR 206.00
+2.00 (0.98%)
Inactive · Last trade price on Apr 17, 2026
Ascendis Pharma Employees
Ascendis Pharma had 1,189 employees as of December 31, 2025. The number of employees increased by 172 or 16.91% compared to the previous year.
Employees
1,189
Change (1Y)
172
Growth (1Y)
16.91%
Revenue / Employee
€605,662
Profits / Employee
€191,786
Market Cap
12.18B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,189 | 172 | 16.91% |
| Dec 31, 2024 | 1,017 | 138 | 15.70% |
| Dec 31, 2023 | 879 | 82 | 10.29% |
| Jan 1, 2023 | 797 | 158 | 24.73% |
| Dec 31, 2021 | 639 | 157 | 32.57% |
| Dec 31, 2020 | 482 | 152 | 46.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Ascendis Pharma News
- 15 days ago - Ascendis Pharma initiated with a Buy at Citi - TheFly
- 19 days ago - Ascendis Pharma price target raised to $329 from $324 at Evercore ISI - TheFly
- 23 days ago - Ascendis Pharma price target raised to $345 from $342 at Barclays - TheFly
- 26 days ago - Ascendis Pharma price target lowered to $326 from $330 at Wells Fargo - TheFly
- 27 days ago - Ascendis Pharma reports Q1 adjusted EPS EUR 0.29, consensus EUR (0.15) - TheFly
- 27 days ago - Ascendis Pharma Earnings Call Transcript: Q1 2026 - Transcripts
- 27 days ago - Ascendis Pharma Earnings release: Q1 2026 - Filings
- 27 days ago - Ascendis Pharma Reports First Quarter 2026 Financial Results - GlobeNewsWire